Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Drug - Device Combinations Are an Emerging Part of the Drug Delivery Systems Market: companiesandmarkets.com

Abstract:
- Drug-device combinations offer high levels of efficacy, fewer side effects and sustained drug release
- Miniaturization is a key trend in drug delivery and medical devices
- Further biomaterials R&D required to ensure suitability of drug coatings'

Drug - Device Combinations Are an Emerging Part of the Drug Delivery Systems Market: companiesandmarkets.com

London, UK | Posted on August 31st, 2011

For serious conditions, treatment regimes using combination drug-devices are proving to be effective in enhancing patient lifespan according to a new research report available on companiesandmarkets.com. These techniques have been shown to reduce the level of toxicity within organs, as well as lengthening patients' lives.

Combination Devices - Application Landscape
www.companiesandmarkets.com/Market-Report/combination-devices-application-landscape-684509.asp?prk=7c4ed5b510c1ffe12b50d9829eddaba2

Combination drug-devices are revolutionising the manner in which drugs are administered to patients: their targeted approach reduces unwanted side effects and allows for a higher dose of the drug to be delivered to the appropriate site.

Developed using biomaterials, nanotechnology, photodynamic therapy and many other techniques, drug-device combinations are an emerging part of the drug delivery systems market. Support has grown for this drug delivery approach following promising clinical research, and major developments in the associated technologies. Major advances in the field of imaging technologies have made it easier for researchers to observe the combination devices drug delivery process, to determine the feasibility and efficacy of the technique.

Using drug-device combinations, cancer treatments such as docetaxel can now be carried through the body within silica nanorattles and released over time, and at an appropriate pH. The focus on cancer drugs stems from the fact that a two-pronged approach must be taken to address the heterogeneity of the tumor itself, as well as its adaptive resistance. Drug-device combination therapies are proving plausible methods of addressing both requirements.

Spin-off companies and technology licensing are expected next steps within the market, as commercialization is an expensive process. Smaller companies and research groups are likely to pursue collaborations or partnerships with pharmaceutical and medical device companies.

The 68 page, June 2011 report, provides the reader with a detailed insight into the combination drug devices market. It includes information on key market players, products, patents, technology overviews and opportunity evaluation. Three key markets are discussed in detail:diagnostic tools, bacteriophages and antibiotics.

The report also includes information and statistics on healthcare expenditure, cancer and cardiovascular disease incidence and pharmaceutical expenditure on R&D.

####

For more information, please click here

Contacts:
Paul Chapman
Press Office
Companies & Markets

London (UK): +44 (0) 203 086 8600

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

INVECAS to Enable ASIC Designs for Tomorrows Intelligent Systems on GLOBALFOUNDRIES' FDX Technology: INVECAS to Collaborate with GLOBALFOUNDRIES to Provide IP and End-to-End ASIC Design Services on 22FDX and 12FDX Technologies September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Innovation in Nanotechnology is Focus of Symposium: Annual event brings international experts to Northwestern Oct. 6 September 29th, 2016

Possible Futures

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Nanosensors could help determine tumors ability to remodel tissue: Measuring enzyme levels could help doctors select appropriate treatments September 29th, 2016

Crystalline Fault Lines Provide Pathway for Solar Cell Current: New tomographic AFM imaging technique reveals that microstructural defects, generally thought to be detrimental, actually improve conductivity in cadmium telluride solar cells September 26th, 2016

Nanomedicine

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Nanosensors could help determine tumors ability to remodel tissue: Measuring enzyme levels could help doctors select appropriate treatments September 29th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Announcements

Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016

INVECAS to Enable ASIC Designs for Tomorrows Intelligent Systems on GLOBALFOUNDRIES' FDX Technology: INVECAS to Collaborate with GLOBALFOUNDRIES to Provide IP and End-to-End ASIC Design Services on 22FDX and 12FDX Technologies September 30th, 2016

How to power up graphene implants without frying cells: New analysis finds way to safely conduct heat from graphene to biological tissues September 30th, 2016

Innovation in Nanotechnology is Focus of Symposium: Annual event brings international experts to Northwestern Oct. 6 September 29th, 2016

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Nanosensors could help determine tumors ability to remodel tissue: Measuring enzyme levels could help doctors select appropriate treatments September 29th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016

Crystalline Fault Lines Provide Pathway for Solar Cell Current: New tomographic AFM imaging technique reveals that microstructural defects, generally thought to be detrimental, actually improve conductivity in cadmium telluride solar cells September 26th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic